On this page
Study design
Researchers used stool metagenomic sequencing and clinical assessments in 121 drug-naïve young adults with first-episode major depressive disorder and 117 matched healthy controls. The assessment included depression severity and a standardized cognitive battery.
Findings
The groups differed in microbial diversity and in several species, microbial genes and metabolic pathways. Some bacterial and viral species tracked cognitive scores, including an association between Bifidobacterium pseudocatenulatum and attention/vigilance within the depression group. A model combining multiple microbial kingdoms performed better for distinguishing the groups than a bacteria-only model in the study.
Limits
This was an observational comparison at one time point, not a test of probiotics or another treatment. Associations with cognition do not establish direction or causation, and machine-learning classification in this sample is not a validated diagnostic test. The findings need independent replication.
This sourced news summary and translation were prepared with AI assistance. Source links, the news date and research limitations are disclosed; this is not a claim of independent medical expert review. News production method.
Sources
- Integrative multi-kingdom gut microbiome analysis uncovers clinical signatures of major depressive disorder — Journal of Affective Disorders / Elsevier ·
Research news is not medical advice or a recommendation to use a substance. Read findings in the context of the study design, participants and limitations. Editorial standards.
← All news